4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-062290
Chief Executive Officer sold 110,694 shares at $4.88 ($540,187)
- Chief Executive Officer acquired 44,642 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2019-12-27 | Option exercise | +44,642 | $2.24 | $99,998 | 1,843,967 | D |
| Cooper Laurence James Neil Chief Executive Officer | 2019-12-30 | Sale | −110,694 | $4.88 | $540,187 | 1,733,273 | D |
| Derivatives | |||||||
| Cooper Laurence James Neil Chief Executive Officer | 2019-12-27 | Option exercise · Employee Stock Option (right to buy) | −44,642 | 487,171 | D | ||
| Open-market sales · 110,694 sh · avg $4.88 · $540,187 | |||||||
Loading xslF345X03/doc4.xml…